PATADAY ONCE DAILY RELIEF

NDA 206276 · New Drug Application (NDA) Over-the-counter

OLOPATADINE HYDROCHLORIDE

Sponsor (Drugs@FDA)
ALCON LABS INC Company: ALCON INC (ALC)
First approved
Latest action

Drugs on HealthTrade

No drug on HealthTrade cites this application. Novel approvals since 2015 by healthcare companies HealthTrade covers are listed from Drugs@FDA automatically, labelled “Not yet reviewed”; editors link the others.

Products

Drugs@FDA products under NDA 206276, with Orange Book listing details
ProductName and ingredientForm and strengthMarketing statusTE codeReferenceOrange Book
001 PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 0.7% BASEOver-the-counter– Reference listed drug, Reference standard OTCApproved

Submissions

FDA submissions for NDA 206276, newest first
SubmissionStatusStatus dateReviewClassDocuments
Supplement 11ApprovedstandardLabelingLetter for Supplement 11 (opens in a new tab)Label for Supplement 11 (opens in a new tab)
Supplement 6Approvedn/aManufacturing (CMC)Label for Supplement 6 (opens in a new tab)
Supplement 5ApprovedstandardEfficacyLetter for Supplement 5 (opens in a new tab)Label for Supplement 5 (opens in a new tab)
Supplement 1ApprovedpriorityManufacturing (CMC)None listed
Original 1ApprovedpriorityType 5 - New Formulation or New ManufacturerLetter for Original 1 (opens in a new tab)Label for Original 1 (opens in a new tab)

Orange Book patents

2 patents listed, as the Orange Book prints them.

Orange Book patents for NDA 206276
PatentExpiresClaimsUse codeSubmitted
8791154Product 001 Drug product U-1680
9533053Product 001 Drug product –

Orange Book exclusivities

No Orange Book exclusivities are listed for this application.

Prescription labels

No human prescription label in openFDA cites this application.

NDC products

1 product in the NDC directory with this application number.

NDC directory products for NDA 206276
Product NDCNameLabelerForm and routeCategoryMarketing dates
0065-0816 in openFDA (opens in a new tab) PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDEAlcon Laboratories, Inc. SOLUTION OPHTHALMICNDA From

FDA recalls load here.

FDA drug shortages load here.

Sources

Data provided by the U.S. Food and Drug Administration. Showing it here is not an FDA endorsement. openFDA asks: “Do not rely on openFDA to make decisions regarding medical care.”

Patent and exclusivity dates are as FDA lists them and can change. Nothing on this page is medical or investment advice.